Lomb Scientific is backed by private equity and has undergone investment activity.
Alternatives.pe tracks Lomb Scientific's investment history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
On 27 December 2010, Anacacia Capital exited its investment through the sale of Lomb Scientific to Thermo Fisher Scientific Inc. (NYSE: TMO).
Anacacia sold Lomb Scientific to Thermo Fisher Scientific, a U.S.-based life sciences company, in a ... see summary
Anacacia bought into Lomb in April 2008. The financial terms of the transaction remain undisclosed.
In April 2008, Anacacia Capital, an Australia-based private equity firm, acquired Lomb Scientific.